Can-Fite BioPharm Exercises Warrants for $4 Million Proceeds

Clinical-stage biopharmaceutical company Can-Fite has exercised outstanding warrants, generating approximately $4.0 million in gross proceeds to support its development pipeline.

2 Sept, 13:02 — 2 Sept, 13:02

Post Share

Sources

Showing 1 of 1 sources

taiwan-newsMostly Factual1d ago

Can-Fite Announces Exercise of Warrants for Approximately $4.0 Million in Gross Proceeds - taiwannews.com.tw

Can-Fite Announces Exercise of Warrants for Approximately $4.0 Million in Gross Proceeds taiwannews.com.tw

Read full article →

Can-Fite BioPharm Exercises Warrants for $4 Million Proceeds

Sources

Can-Fite Announces Exercise of Warrants for Approximately $4.0 Million in Gross Proceeds - taiwannews.com.tw

Related Stories

Volkswagen Approves Restructuring Plan to Slash 100,000 Jobs by 2030

Trump Administration Seeks Supreme Court Approval for Mail Ballot Restrictions

New US-Venezuela Oil Agreement Draws Sharp Criticism and Economic Skepticism

Crusoe Secures $3 Billion Funding and Lands $13 Billion Cloud Deal